JP2009543799A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543799A5
JP2009543799A5 JP2009519632A JP2009519632A JP2009543799A5 JP 2009543799 A5 JP2009543799 A5 JP 2009543799A5 JP 2009519632 A JP2009519632 A JP 2009519632A JP 2009519632 A JP2009519632 A JP 2009519632A JP 2009543799 A5 JP2009543799 A5 JP 2009543799A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
amount
methoxy
furfuryl
disubstituted purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009519632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009543799A (ja
JP5309023B2 (ja
Filing date
Publication date
Priority claimed from US11/774,652 external-priority patent/US20080009508A1/en
Application filed filed Critical
Publication of JP2009543799A publication Critical patent/JP2009543799A/ja
Publication of JP2009543799A5 publication Critical patent/JP2009543799A5/ja
Application granted granted Critical
Publication of JP5309023B2 publication Critical patent/JP5309023B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009519632A 2006-07-10 2007-07-10 6,9−二置換プリン誘導体および皮膚を処置するためのその使用 Expired - Fee Related JP5309023B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80687106P 2006-07-10 2006-07-10
US60/806,871 2006-07-10
US11/774,652 US20080009508A1 (en) 2006-07-10 2007-07-09 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
US11/774,652 2007-07-09
PCT/US2007/073142 WO2008008770A2 (en) 2006-07-10 2007-07-10 6, 9-disubstituted purine derivatives and their use for treating skin

Publications (3)

Publication Number Publication Date
JP2009543799A JP2009543799A (ja) 2009-12-10
JP2009543799A5 true JP2009543799A5 (https=) 2010-09-09
JP5309023B2 JP5309023B2 (ja) 2013-10-09

Family

ID=38919793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519632A Expired - Fee Related JP5309023B2 (ja) 2006-07-10 2007-07-10 6,9−二置換プリン誘導体および皮膚を処置するためのその使用

Country Status (16)

Country Link
US (4) US20080009508A1 (https=)
EP (1) EP2043630B1 (https=)
JP (1) JP5309023B2 (https=)
KR (1) KR101478727B1 (https=)
CN (1) CN101646435B (https=)
AU (1) AU2007272576B2 (https=)
BR (1) BRPI0714161A2 (https=)
CA (1) CA2657516C (https=)
EA (1) EA015848B1 (https=)
ES (1) ES2603216T3 (https=)
IL (1) IL196442A (https=)
MX (1) MX2009000347A (https=)
MY (1) MY158100A (https=)
NO (1) NO20090598L (https=)
NZ (1) NZ574711A (https=)
WO (1) WO2008008770A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960397B2 (en) * 2007-12-28 2011-06-14 Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
CN104945420A (zh) 2009-06-29 2015-09-30 因塞特公司 作为pi3k抑制剂的嘧啶酮类
US8680108B2 (en) * 2009-12-18 2014-03-25 Incyte Corporation Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
AR081823A1 (es) 2010-04-14 2012-10-24 Incyte Corp DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
US9096852B2 (en) 2010-06-09 2015-08-04 Chanel Parfums Beaute Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
EP2395086A1 (en) * 2010-06-09 2011-12-14 Chanel Parfums Beauté Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
EP2655374B1 (en) 2010-12-20 2019-10-23 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
KR102507287B1 (ko) 2011-09-02 2023-03-07 인사이트 홀딩스 코포레이션 Pi3k 억제제로서 헤테로시클릴아민
US20130072506A1 (en) 2011-09-16 2013-03-21 Lenka ZAHAJSKA 6,8-disubstituted purine compositions
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
CZ306984B6 (cs) * 2014-12-15 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 6,8-Disubstituované-9-(heterocyklyl)puriny, přípravky obsahující tyto deriváty a jejich použití v kosmetických a medicínských aplikacích
SI3831833T1 (sl) 2015-02-27 2023-03-31 Incyte Holdings Corporation Postopki za pripravo inhibitorja PI3K
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
CZ307722B6 (cs) * 2015-08-28 2019-03-27 Univerzita PalackĂ©ho v Olomouci Adeninové deriváty a jejich použití
CZ307868B6 (cs) 2017-04-28 2019-07-10 Univerzita PalackĂ©ho v Olomouci Deriváty 9-(2-oxacykloalkyl)-9H-purin-2,6-diaminu, přípravky obsahující tyto deriváty a jejich použití
CA3101323A1 (en) 2018-06-01 2019-12-05 Incyte Corporation Dosing regimen for the treatment of pi3k related disorders
EP4178959B1 (en) 2020-07-13 2025-09-10 Univerzita Palackého v Olomouci Nitrogen heterocyclic cytokinin derivatives, compositions containing these derivatives and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371089A (en) * 1987-02-26 1994-12-06 Senetek, Plc Method and composition for ameliorating the adverse effects of aging
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
WO2004037159A2 (en) * 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
KR20060070572A (ko) * 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Hsp90-저해제로서의 신규 헤테로시클릭 화합물
WO2007007255A2 (en) * 2005-07-08 2007-01-18 The Procter & Gamble Company Personal care compositions and methods for the beautification of mammalian skin and hair

Similar Documents

Publication Publication Date Title
JP2009543799A5 (https=)
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2018135343A5 (https=)
JP2012508734A5 (https=)
JP2010521514A5 (https=)
ES2611483T3 (es) Agente terapéutico para enfermedad inflamatoria intestinal
JP2012184234A5 (https=)
JP2013534248A5 (https=)
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
JP2011522816A5 (https=)
JP2010265321A5 (https=)
JP2014515013A5 (https=)
JP2012500004A5 (https=)
JP2016520618A5 (https=)
JP2010155827A5 (https=)
JP2009533356A5 (https=)
JP2013528655A5 (https=)
JP2008500999A5 (https=)
JP2013509411A5 (https=)
MX337396B (es) Metodo para el tratamiento de enfermedades del riñon poliquisticas con derivados de ceramica.
JP2011046708A5 (https=)
JP2013510169A5 (https=)
JP2008512426A5 (https=)
JP2009501202A5 (https=)
JP2012508256A5 (https=)